Preparative isolation and structural elucidation of impurities in fluconazole by LC/MS/MS

Journal of Pharmaceutical and Biomedical Analysis

Volumn 42, Issue 3, 2006, Pages 334-340

  Dongre, Vaijanath G ^a   Karmuse, Pravin P ^a,b   Ghugre, Pradeep D ^a,b   Salunke, Sanjukumar M ^b   Panda, Nalinakshya ^b   Kumar, Ashok ^b  

^a UNIVERSITY OF MUMBAI   (India)

^b Ipca Laboratories Ltd   (India)

Author keywords

Fluconazole; Identification; Impurities; IR; Isolation; LC MS MS; NMR; Preparative HPLC

Indexed keywords

1 (1H 1,2,4 TRIAZOL 1 YL) PROPANE 2,3 DIOL; 2 (2,4 DIFLUOROPHENYL) 3 (1H 1,2,4 TRIAZOL 1 YL) 2 PROPEN 1 OL; FLUCONAZOLE; PROPANE; UNCLASSIFIED DRUG;

ARTICLE; CHEMICAL STRUCTURE; DRUG IMPURITY; ELECTROSPRAY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INFRARED SPECTROSCOPY; ION TRAP MASS SPECTROMETRY; ISOLATION PROCEDURE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; STRUCTURE ANALYSIS; SYNTHESIS; TANDEM MASS SPECTROMETRY;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG CONTAMINATION; FLUCONAZOLE; MASS SPECTROMETRY;

EID: 33748346862     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2006.04.012     Document Type: Article

References (13)

1. In: Reynolds E.F. (Ed). Martindale-The Extra Pharmacopoeia (1996), Royal Pharmaceutical Society of Great Britain 405
2. Hadman J.G., and Limbird L.E. The Pharmacological Basis of Therapeutics. 10th ed. (2001), McGraw Hill p. 1304
3. Braunwald E. Harrison's Principle of Internal Medicine. 15th ed. (2003), McGraw Hill p. 1170
4. United state Pharmacopeia, Pharmacopeial Forum, vol. 31, 2005, pp. 408-410.
5. Chinese Pharmacopeia, vol. 2, 2000, p. 290.
6. European Pharmacopoeia, Pharmacopeial Forum, vol. 16, 2004, pp. 441-442.
7. Creaser C.S., Stygall J.W., Bower D.V., and Pullen F.S. Talanta 44 (1997) 1025-1035
8. Cyr T.D., Dawson B.A., Neville G.A., and Shurvell H.F. J. Pharm. Biomed. Anal. 14 (1996) 247-255
9. Sun S., Lou H., Gao Y., Fan P., Ma B., Ge W., and Wang X. J. Pharm. Biomed. Anal. 34 (2004) 1117-1124
10. Eerkes A., Shou W.Z., and Naidong W. J. Pharm. Biomed. Anal. 31 (2003) 917-928
11. ICH guideline, Impurities in new drug substances Q3A (R1) dated February 7, 2002.
12. Narayanan A., Chapman D.R., Upadhyaya S.P., and Bauer L. J. Heterocycl. Chem. 30 (1993) 1405-1412
13. Eliel E.L., and Wilen S.H. Stereochemistry of Organic Compounds (1994), Wiley Interscience publication pp. 572-573